yh 1885 has been researched along with Gastric Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hahm, KB; Hong, H; Kim, EH; Kim, JH; Kim, YJ; Kwon, KA; Ock, C; Park, DK | 1 |
1 other study(ies) available for yh 1885 and Gastric Diseases
| Article | Year |
|---|---|
Mitigating endoplasmic reticulum stress with revaprazan ameliorates stress-related mucosal disease.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Cell Line; Cytoprotection; Disease Models, Animal; DNA-Binding Proteins; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Gastric Mucosa; Heat-Shock Proteins; Immersion; Inflammation Mediators; Metabolic Detoxication, Phase II; Mice; Proton Pump Inhibitors; Pyrimidinones; Rats; Rats, Wistar; Regulatory Factor X Transcription Factors; Severity of Illness Index; Stomach Diseases; Stress, Physiological; Stress, Psychological; Tetrahydroisoquinolines; Time Factors; Transcription Factor CHOP; Transcription Factors; X-Box Binding Protein 1 | 2012 |